心脏外科与介入治疗狭窄冠状动脉研究评分联合连续心率减速力在急性冠状动脉综合征患者中的临床研究

Clinical study of Synergy between pereu-taneous coronary intervention with TAXUS and cardiac surgery score combined with continuous heart rate deceleration in acute coronary syndrome patients

目的探讨心脏外科与介入治疗狭窄冠状动脉研究(SYNTAX)评分联合连续心率减速力(DRS)在急性冠状动脉综合征(ACS)患者中的临床应用价值。方法选择2018年6月至2019年12月在广东医科大学非附属高明区人民医院心血管内科住院期间确诊ACS患者70例,确诊后均行经皮冠状动脉介入手术(PCI)术,其中以有SYNTAX联合DRS评估(ACS前评估)为实验组,无ACS前评估为对照组,研究其发病时的患者时间、支架植入成功率、术中慢血流或无复流的发生率、ST段回落率、不良心脏事件(MACE)的差异性。结果SYNTAX、DRS分别评分得出的低、中、高危组MACE发生率逐渐升高,差异有统计学意义;有ACS评分较无ACS评分患者时间明显缩短、支架植入成功率无明显改变、术中慢血流或无复流的发生率下降、ST段回落率上升、不良心脏事件(MACE)发生率下降。结论有必要对存在ACS风险患者进行评估,可缩短患者时间,提高救治效果,降低病死率。

Objective To evaluate the clinical value of Synergy between pereu-taneous coronary intervention with TAXUS and cardiac surgery(SYNTAX)score combined with continuous heart rate deceleration(DRS)in acute coronary syndrome(ACS)patients.Methods From June 2018 to December 2018,70 patients with ACS were selected from department of cardiovascular medicine,people's Hospital,Gaoming District,Guangdong Medical University.patents diagnosed in our hospital were treated with percutaneous coronary intervention(PCI).The experimental group was treated with SYNTAX combined with continuous heart rate deceleration assessment(ACS pre-evaluation).No ACS was assessed as a control group.The time of onset,the success rate of stent implantation,the incidence of slow blood flow or no reflow during operation,the rate of ST segment fall,and the difference of Major adverse cardiovascular events(MACE)in adverse cardiac events were studied.Results The incidence of MACE in the high risk group was significantly higher than that in the low,middle and high risk group with SYNTAX,DRS score.The time of patients with ACS score was shorter than that without ACS score,the success rate of stent implantation had no obvious change,the incidence of slow blood flow or no reflow during operation was decreased,the ST segment receding rate was increased,and the incidence of adverse cardiac events(MACE)was decreased.Conclusion It is necessary to evaluate the patients at risk of ACS,which can help shorten the time of patients,improve the therapeutic effect and reduce the mortality.